Research

IUD in hand

Research projects are continuously being developed and implemented within the Family Planning Division. Past and present research includes evaluating the effectiveness and satisfaction of a levonorgestrel-releasing intrauterine system (IUD) for long-term, reversible contraception and the effectiveness of the insertion device. Faculty members within the Obstetrics & Gynecology department have developed a semi-quantitative pregnancy test that is being studied for post-abortion care and in vitro fertilization (IVF) treatment, and a dedicated IUD inserter for use in post delivery settings both domestically and internationally.

Fellowship research projects have included simplifying methods for IUD insertion and improving patient access and experience during 2nd trimester pregnancy termination by evaluating the effectiveness of Mifepristone during treatment.

 

For more information about any current or past research projects or inquiries about potential collaboration or participation, please e-mail: 
familyplanningresearch@stanford.edu

Measuring hCG Levels in Pregnant Women: A Prenatal Study of hCG Using a Multi-Level Pregnancy Test and Serum Testing

Understanding hCG patterns among women over 63 days gestation is important for developing strategies for pregnancy testing in a number of populations. This study seeks to assess trends in hCG between the 9th and 12th weeks of gestation by comparing blood hCG serum levels with the results of a multi-level pregnancy test (MLPT).

This study is actively seeking participants, please e-mail familyplanningresearch@stanford.edu for more information. 

Principal Investigator: Paul D Blumenthal, MD, MPH

Labor and Delivery Implant Insertion (LADII): A randomized controlled trial

The objective of this study is to compare the immediate insertion of the contraceptive implant to delayed insertion (before hospital discharge following delivery) and breastfeeding outcomes between timing of insertion.

This study is ongoing and currently recruiting patients presenting to labor and delivery who desire a contraceptive implant for postpartum contraception. Please contact us for more information familyplanningresearch@stanford.edu.

Principal Investigator: Kate A. Shaw, MD, MSc

Medication Abortion Self-Confirmation (MASC): Comparison of Two Home Pregnancy Tests as an Alternative to Office Follow-up

The objective of this study is to assess patient comprehension of MLPT and LSPT after medication abortion. This study is ongoing and currently recruiting patients presenting to clinic for medication abortion for pregnancies through 63 days gestation.

Please email familyplanningresearch@stanford.edu for more information.

Principal Investigator: Wing Kay Fok, MD

Multi-center, open-label, uncontrolled study to assess contraceptive efficacy and safety of Mirena during extended use beyond 5 years in women 18 to 35 years of age including a subgroup evaluation of treatment effect on heavy menstrual bleeding

The primary objective of this study is to assess the contraceptive efficacy of Mirena beyond 5 years up to 8 years of use. Secondary objectives are the assessment of menstrual blood loss in women who had the Mirena inserted for the indication of heavy menstrual bleeding.

This study is ongoing and actively recruiting patients. Please email familyplanningresearch@stanford.edu for more information.

Principal Investigator: Paul D Blumenthal, MD, MPH